If 15mg side effects are impairing your quality of life or preventing adequate nutrition, stepping back to 12.5mg is highly recommended
A report from the EMAs PRAC, published on 12 April 2024, said: After reviewing the available evidence from non-clinical studies, clinical trials, post-marketing surveillance data and the available studies the PRAC considers that no update to the product information is warranted. The PRAC statement said that market authorisation holders would continue to monitor events, including new studies, as part of their pharmacovigilance activities
Understanding Semaglutide Semaglutide is a groundbreaking pharmaceutical agent, lauded for its effectiveness in treating type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)
Laser and IPL options carry a higher risk of pigmentation changes in darker skin tones and require careful provider selection
Secondly, it suppresses the release of glucagon, a hormone that raises blood sugar levels